Reporter : Qiao An / https://www.ntdtv.com/gb/2020/11/13/a102986483.html / Translation, editing : Gan Yung Chyan, KUCINTA SETIA / Image : Video Screenshot
On Friday (November 13), US President Trump (Trump) delivered his first public speech in the Rose Garden of the White House in more than a week, introducing the development of SARS-CoV-2 (CCP virus) vaccines and The latest developments in drug "Operation Warp Speed" action.
U.S. President Trump: "In the past nine months, this administration has launched the largest single operation in U.S. history to develop and produce treatments and vaccines at a record speed, an unprecedented speed."
On November 9, as one of the participants in the Trump administration’s “speedy action”, Pfizer Pharmaceuticals of the United States and its German partner BioNTech announced the preliminary data of the third phase of clinical trials, showing that the effectiveness of the Chinese virus vaccine developed by it exceeds 90%, it is expected that after obtaining complete data, it will be approved by the Federal Food and Drug Administration (FDA) quickly, and it will be provided to susceptible people such as the elderly before the end of this year.
US President Trump said, "We will work hard to ensure that an emergency use authorization can be approved soon, and then my government will coordinate the distribution of the vaccine, it will be approved, and I think it will be approved very quickly."
The Trump administration and Pfizer have reached an agreement to invest US$195 million in ordering 100 million CCP virus vaccines. At the same time as the agreement with the Trump administration, there are three other vaccine research and development institutions. It is expected that the United States will have at least two CCP virus vaccines before the end of this year. The CCP virus vaccine has been approved and can be distributed to all people as soon as April next year.
In terms of special medicines, the Trump administration has also invested a lot of money to support research and development. The FDA approved "Remdesivir" as a special medicine against the CCP virus in October. In addition, some antibody therapies have also shown amazing efficacy. The Trump administration has just reached an agreement with Eli Lilly to order the company's first antibody preparations and provide them to patients free of charge.
On the same day, Trump once again stated that as long as he continues to govern, the United States will never fall into a national lockdown again because of the pandemic.
No comments:
Post a Comment